Cite

    Hernani, R., Piñana, J. L., Pérez, A., Quintero, A., Montoro, J., Hernández‐Boluda, J. C., Carretero, C., Balaguer‐Roselló, A., Guerreiro, M., Lorenzo, I., Aguilar, C., Giménez, E., Navarro, D., Sanz, M. A., Sanz, J., & Solano, C. (2021). sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis. EJHaem, 2(2), 236–248. http://access.bl.uk/ark:/81055/vdc_100130246951.0x000005